Log in to search using one of your social media accounts:

 

Scientists Make Progress on Blood Test to Detect the Most Deadly Cancers
Scientists are reporting progress on a blood test to detect many types of cancer at an early stage, including some of the most deadly ones that lack screening tools now. Many groups are working on liquid biopsy tests, which look for DNA and other things that tumors shed into blood, to try to find cancer before it spreads, when chances of cure are best. In a study Thursday in the journal Science, Johns Hopkins University scientists looked to see how well their experimental test detected cancer in people already known to have the disease. The blood tests found about 70 percent of eight common types of cancer in the 1,005 pat...
Source: TIME.com: Top Science and Health Stories - January 20, 2018 Category: Consumer Health News Authors: Marilynn Marchione / AP Tags: Uncategorized APH Cancer healthytime onetime Source Type: news

Oral Contraceptives Reduce Risk for Ovarian and Endometrial Cancers
The effect is especially evident in smokers, the obese and those who exercise infrequently. (Source: NYT Health)
Source: NYT Health - January 19, 2018 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Smoking and Tobacco Birth Control and Family Planning Cancer Ovaries Source Type: news

The Pill Lowers Ovarian Cancer Risk, Even for Smokers
Title: The Pill Lowers Ovarian Cancer Risk, Even for SmokersCategory: Health NewsCreated: 1/18/2018 12:00:00 AMLast Editorial Review: 1/19/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - January 19, 2018 Category: Cancer & Oncology Source Type: news

The Pill Lowers Ovarian Cancer Risk, Even for Smokers
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - January 19, 2018 Category: Cancer & Oncology Source Type: news

Pill Cuts Ovarian Cancer Risk, Even for Smokers
According to the study from the U.S. National Cancer Institute, these trends were also observed for endometrial cancer as well. (Source: WebMD Health)
Source: WebMD Health - January 18, 2018 Category: Consumer Health News Source Type: news

The Pill Lowers Ovarian Cancer Risk, Even for Smokers
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 18, 2018 Category: Cancer & Oncology Tags: Gynecology, Obstetrics, Oncology, News, Source Type: news

The Pill Lowers Ovarian Cancer Risk, Even for Smokers
THURSDAY, Jan. 18, 2018 -- It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese. According to the study from the U.S. National Cancer... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 18, 2018 Category: General Medicine Source Type: news

Cancer gene screening more cost effective in the general population than high-risk groups
(Oxford University Press USA) A study published in the Journal of the National Cancer Institute indicates that screening the general population for mutations in specific genes is a more cost effective way to detect people at risk and prevents more breast and ovarian cancers compared to only screening patients with a personal or family history of these diseases. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 18, 2018 Category: Cancer & Oncology Source Type: news

Breast and ovarian cancer: All woman over 30 'should be tested for gene mutations'
ALL BRITISH women over the age of 30 should be tested for breast and ovarian cancer gene mutations to help save lives and cut costs, new research suggests. (Source: Daily Express - Health)
Source: Daily Express - Health - January 18, 2018 Category: Consumer Health News Source Type: news

Heated Intraperitoneal Chemo for Ovarian Cancer Ups Survival Heated Intraperitoneal Chemo for Ovarian Cancer Ups Survival
A single administration of hyperthermic intraperitoneal chemotherapy at the end of cytoreductive surgery improves overall survival in women with advanced ovarian cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 17, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Heated abdominal chemo bath improves ovarian cancer survival
(Reuters Health) - - A heated chemotherapy organ bath circulated throughout the abdomen after surgery can significantly prolong a woman's survival with advanced ovarian cancer, according to doctors testing the new treatment. (Source: Reuters: Health)
Source: Reuters: Health - January 17, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Normal-tissue BRCA1 Methylation May Occur Before Birth, Raise Ovarian Cancer Risk Normal-tissue BRCA1 Methylation May Occur Before Birth, Raise Ovarian Cancer Risk
BRCA1 methylation in normal tissue raises the risk for high-grade ovarian cancer and may occur before birth, according to a study from Norway.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 17, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Ovarian Cancer Symptoms vs Pregnancy
Ovarian Cancer Symptoms vs. Pregnancy (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - January 17, 2018 Category: General Medicine Source Type: news

Whole-population testing for breast and ovarian cancer gene mutations is cost effective
(Queen Mary University of London) Screening the entire population for breast and ovarian cancer gene mutations, as opposed to just those at high-risk of carrying this mutation, is cost effective and could prevent more ovarian and breast cancers than the current clinical approach, according to research published today in the Journal of the National Cancer Institute. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 17, 2018 Category: Cancer & Oncology Source Type: news

BRCA1 Methylation Tied to Ovarian Cancer Risk
(MedPage Today) -- DNA repair gene may be nonfunctional despite'normal'test result (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 16, 2018 Category: Hematology Source Type: news

Normal tissue BRCA1 methylation associated with risk for high-grade ovarian cancer
(American College of Physicians) Normal tissue BRCA1 methylation is associated with risk for high-grade ovarian cancer and may occur as a prenatal event. These findings are published in Annals of Internal Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 15, 2018 Category: Cancer & Oncology Source Type: news

BRCA Breast Cancer Gene Doesn't Affect Survival
BRCA mutations are inherited and increase the risk of breast and ovarian cancers. Between 45 percent and 90 percent of women with a BRCA mutation develop breast cancer, compared with about 12.5 percent of women in the general population. (Source: WebMD Health)
Source: WebMD Health - January 12, 2018 Category: Consumer Health News Source Type: news

First treatment approved for breast cancer with BRCA genetic mutation
The Food and Drug Administration on Friday cleared the first treatment for patients with advanced breast cancer caused by BRCA mutations, which are genetic defects that raise the risk of malignancies. The drug, called Lynparza, already is approved for certain patients with advanced ovarian cancer associated with the same mutations. Richard Pazdur, director of the […]Related:FDA warns against giving kids cough and cold medicines with codeine or hydrocodoneNew study on abortion pill shows high success, low rate of complicationsHe was 21 and fit. He tried to push through the flu — and it killed him. (Source: Wash...
Source: Washington Post: To Your Health - January 12, 2018 Category: Consumer Health News Source Type: news

Neoadjuvant Chemotherapy Tied to Better Survival in Advanced Ovarian Cancer Neoadjuvant Chemotherapy Tied to Better Survival in Advanced Ovarian Cancer
The adoption of neoadjuvant chemotherapy is associated with reduced mortality in women with advanced epithelial ovarian cancer, researchers report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 10, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Tumor Microvessel Density as Marker for Bevacizumab Benefit Tumor Microvessel Density as Marker for Bevacizumab Benefit
What are the potential predictive and prognostic effects of these five biomarkers in patients with ovarian cancer?Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 9, 2018 Category: Consumer Health News Tags: None Journal Article Source Type: news

Fighting ovarian cancer as a student
A student who was diagnosed with ovarian cancer in her first year of university has created videos and animations to help other young people through illness. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - January 8, 2018 Category: Consumer Health News Source Type: news

Neoadjuvant Chemotherapy Tied to Improved Ovarian Cancer Survival
In women with advanced ovarian cancer, increased use of neoadjuvant chemotherapy (NACT) followed by surgery — rather than primary cytoreductive surgery — is associated with reduced mortality... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 5, 2018 Category: Primary Care Source Type: news

A new therapeutic target to fight metastasis in ovarian cancer
(IDIBELL-Bellvitge Biomedical Research Institute) Researchers of IDIBELL - ICO have described a key cellular receptor in the processes of metastasis in ovarian cancer. The finding might lead to the use of inhibitors of this receptor as a therapeutic target in the most aggressive variants of the disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 4, 2018 Category: International Medicine & Public Health Source Type: news

Serum-DNA Methylation Patterns Might Allow Early Identification of Breast, Ovarian Cancer Serum-DNA Methylation Patterns Might Allow Early Identification of Breast, Ovarian Cancer
Methylation patterns in serum DNA might allow for the early identification of disseminated breast cancer and ovarian cancer, according to two new reports from the U.K.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 2, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

CDC Confirms Persisting Racial Disparities in Cancer Survival
Survival disparities for black patients with ovarian, colon, and breast cancer and childhood ALL suggest a need for efforts toward improved screening and treatment adherence in this population. (Source: CancerNetwork)
Source: CancerNetwork - January 2, 2018 Category: Cancer & Oncology Authors: Bryant Furlow Tags: News Practice & Policy Source Type: news

Jury Awards $22M in Asbestos-Contaminated Paint Case
A California jury recently awarded $22 million to the estate of a man exposed to asbestos-containing talc that was used in paint manufacturing, expanding the liability of those supplying the toxic ingredient. Plaintiff Richard Booker, who worked as a paint maker throughout his career, died of mesothelioma in 2016. The lawsuit claimed Booker was exposed to asbestos while working for Dexter Midland Chemical Co. and Walter N. Boysen Paint Co. The lucrative award includes $4.6 million in punitive damages, along with the initial judgement of $17.57 million for malice on the part of Vanderbilt Minerals and Imerys Talc America In...
Source: Asbestos and Mesothelioma News - January 2, 2018 Category: Environmental Health Authors: Daniel King Tags: Alameda County asbestos exposure asbestos-contaminated talc Cashmere Bouquet Colgate-Palmolive Dexter Midland Chemical Imerys Talc America mesothelioma lawsuit Richard Booker Vanderbilt Minerals Walter N. Boysen Paint Source Type: news

To Give Cancer Survivors a Chance to Conceive, Scientists are Designing Artificial Ovaries
The goal is to house patients' follicles in a specially designed tissue matrix and reinsert them after treatment. (Source: The Scientist)
Source: The Scientist - January 1, 2018 Category: Science Tags: News & Opinion,News Analysis Source Type: news

Top 10 Mesothelioma News Stories of 2017
Every year, mesothelioma specialists and researchers make strides to advance the standard of care, improve treatment strategies and develop new diagnostic practices. Mesothelioma remains a rare cancer, with an estimated 3,000 people diagnosed each year in the U.S., but the fight to find a cure only grows stronger. And while researchers are busy finding breakthroughs in care, advocates are hard at work campaigning for a ban on asbestos, the main cause of mesothelioma. This was a memorable year on both fronts. Immunotherapy continues to be the hot topic among emerging treatments. Drugs such as pembrolizumab (Keytruda) and ni...
Source: Asbestos and Mesothelioma News - December 22, 2017 Category: Environmental Health Authors: Daniel King Tags: canada asbestos ban Food and Drug Administration Furthering Asbestos Claims Transparency Act keytruda Medical marijuana mesothelioma mesothelioma vaccine Opdivo Scott Pruitt talcum powder lawsuit yervoy Source Type: news

Living With Cancer: Immortality at Midnight
Despite a poor cancer prognosis, it thrills me to awaken at 2 or 3 a.m. Trepidation and grief dissolve in the weird awareness of still being alive. (Source: NYT Health)
Source: NYT Health - December 21, 2017 Category: Consumer Health News Authors: SUSAN GUBAR Tags: Cancer Sleep Ovarian Cancer Source Type: news

Newlywed discovers her 'heavy period ’ was terminal cancer
Talitha Sargeant, of West Sussex, assumed her regular period had started. But just 2 months after marrying soulmate Mathew, she was told the devastating news – she had ovarian cancer, (Source: the Mail online | Health)
Source: the Mail online | Health - December 21, 2017 Category: Consumer Health News Source Type: news

Mesothelioma Immunotherapy Clinical Trial Ends Abruptly
A leading biopharmaceutical company has halted a once-promising mesothelioma clinical trial involving CRS-207 — a listeria-based cancer vaccine — citing efficacy and financial concerns. The phase II trial was designed to test the effectiveness and safety of CRS-207 when used in combination with pembrolizumab (Keytruda), a drug already proven effective with non-small cell lung cancer. The trial, which began earlier this year, was being conducted at eight prominent cancer centers across the United States. It was funded by Aduro Biotech Inc., based in Berkley, California. “This was not the news everyone had ...
Source: Asbestos and Mesothelioma News - December 19, 2017 Category: Environmental Health Authors: Daniel King Tags: Abramson Cancer Center Aduro Biotech Cleveland Clinic CRS-207 H. Lee Moffitt Cancer Center keytruda Listeria virus Mayo Clinic mesothelioma immunotherapy Natalie Sacks NIH National Cancer Institute pembrolizumab Perlmutter Cancer C Source Type: news

Novel combination therapy shown to be effective in ovarian cancer
(The Wistar Institute) Wistar researchers have found combining PARP inhibitors, recently approved for the treatment of BRCA-mutant ovarian cancer, with another small molecule inhibitor was effective to treat ovarian cancers without BRCA1 and BRCA2 gene mutations. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 19, 2017 Category: International Medicine & Public Health Source Type: news

GnRH Analogue Use Preserves Fertility During Chemotherapy GnRH Analogue Use Preserves Fertility During Chemotherapy
Meta-analysis confirms that the use of a GnRH analogue during chemotherapy helps preserve ovarian function and fertility in young women undergoing treatment for early breast cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 18, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Drug that holds back return of ovarian cancer gets UK licence
Niraparib, which can buy months of time before relapse after chemotherapy, is yet to be assessed for free availability on NHSA pill treatment that holds back ovarian cancer and has the potential to prolong life has been launched in the UK.Trial results have shown that niraparib, taken once daily, can buy months of time before the disease returns after chemotherapy.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - December 18, 2017 Category: Science Authors: Press Association Tags: Ovarian cancer Health UK news Society Medical research Science Source Type: news

'Milestone' pill that halts spread of ovarian cancer
Daily pills that halt the spread of ovarian cancer have been licensed for use in the UK, in a step greeted as a ‘critical milestone’ for thousands of women. (Source: the Mail online | Health)
Source: the Mail online | Health - December 18, 2017 Category: Consumer Health News Source Type: news

NHS to fund new specialised treatments
Some 3,000 patients with HIV, genetic conditions and skin disorders will benefit Related items fromOnMedica Work needed to boost GPs ’ knowledge of cancer drug Ovarian cancer drug may help stall breast cancer NHS launches mass HIV prevention trials World AIDS Day: The fight against HIV Stevens-Johnson syndrome and toxic epidermal necrolysis (Source: OnMedica Latest News)
Source: OnMedica Latest News - December 18, 2017 Category: UK Health Source Type: news

Study: Preoperative Chemotherapy Useful for Mesothelioma
Oncologists in France are exploring the use of bidirectional chemotherapy as a pre-operative tool for peritoneal mesothelioma, increasing the eligibility of patients for aggressive surgery. Their bidirectional chemotherapy — which typically includes a pemetrexed (Alimta) and cisplatin combination — is delivered directly into the abdominal cavity to reduce tumor burden and make cytoreductive surgery more manageable. Doctors at Gustave Roussy, one of Europe’s premier cancer centers, documented this novel use in a study published in the November issue of Annals of Surgical Oncology. “This is the first ...
Source: Asbestos and Mesothelioma News - December 13, 2017 Category: Environmental Health Authors: Daniel King Tags: bidirectional chemotherapy cytoreductive surgery Gustave Roussy hyperthermic intraperitoneal chemotherapy Paul Sugarbaker peritoneal mesothelioma Washington Cancer Institute Source Type: news

Nigeria:How Do I Spot Ovarian Cancer's Symptoms?
[Vanguard] Dear Bunmi, (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 13, 2017 Category: African Health Source Type: news

Scientists develop new artificial ovary prototype
(Springer) Belgian researchers have taken important steps towards creating transplantable artificial ovaries. Once successful, these could be of value to women struggling with infertility or cancer patients who cannot conceive after undergoing radiation or chemotherapy. The research team has identified a protein formulation that closely resembles the structure and rigidity of the natural tissue lining a woman's ovaries, says Marie-Madeleine Dolmans of the Universit é Catholique de Louvain in Belgium, in an article in Springer's Journal of Assisted Reproduction and Genetics. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - December 13, 2017 Category: International Medicine & Public Health Source Type: news

PET/MRI outclasses MRI alone for pelvic cancer recurrence
PET/MRI can better detect and classify local lesions and distant metastases...Read more on AuntMinnie.comRelated Reading: ASTRO: PET predicts outcomes in vulvar cancer patients PET/MRI matches PET/CT for recurrent pelvic cancer SNMMI: FDG-PET/CT predicts ovarian cancer survival DWI adds little to PET/MRI for female pelvic malignancies PET/MRI matches PET/CT for gynecological malignancies (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 11, 2017 Category: Radiology Source Type: news

Ovarian CA Screening Potentially Cost - Effective in the U.S.
Multimodal screening is more expensive, but reduces ovarian cancer mortality (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 8, 2017 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Oncology, Pathology, Radiology, Journal, Source Type: news

New Study Reinforces Link Between Birth Control & Breast Cancer Risk
By Meera Senthilingam, CNN (CNN) — Birth control can increase a woman’s risk of breast cancer by up to 38%, depending on how long she has taken it, a new study finds. The risk was associated with all forms of hormonal contraception — such as the pill, injections or IUDs — when compared with women who have never used them. Researchers from the University of Copenhagen analyzed data from 1.8 million women under the age of 50 in Denmark. They followed the women for nearly 11 years, on average. The level of breast cancer risk increased the longer a woman had been taking hormonal contraceptives, with the...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - December 7, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News birth control Breast Cancer Source Type: news

Lumicell aims $29m Series C at pivotal breast cancer trial and expansion into other cancers
With $28.7 million from a recently-closed Series C round, Lumicell reported today that it plans to launch a pivotal trial of its image-guided cancer surgery tech in breast cancer. The Wellesley, Mass.-based company added that it hopes to expand its clinical program into other solid tumor cancers, including lung, ovarian and brain cancer. Get the full story at our sister site, Drug Delivery Business News. The post Lumicell aims $29m Series C at pivotal breast cancer trial and expansion into other cancers appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - December 7, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Oncology Pharmaceuticals Surgical Lumicell Source Type: news

Survival in Three Cancers About 10% Better for Whites vs Blacks Survival in Three Cancers About 10% Better for Whites vs Blacks
In terms of cancer survival in the United States, there are'large and persistent'racial differences for ovarian, colon, and breast cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 6, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Colgate-Palmolive Settles Claim Over Asbestos in Talc
Consumer products giant Colgate-Palmolive once again is paying for the alleged link between the company’s Cashmere Bouquet talcum powder and deadly asbestos exposure. The New York-based company agreed to settle a lawsuit claiming a Pennsylvania woman developed mesothelioma after using the talcum powder product for more than 20 years. Colgate-Palmolive avoided a trial in a New Jersey state court with the undisclosed settlement Oct. 30, according to court filings. Plaintiff Carol Schoeniger alleged the company failed to warn her of risks associated with using Cashmere Bouquet, claiming inhaling the asbestos-contaminate...
Source: Asbestos and Mesothelioma News - December 6, 2017 Category: Environmental Health Authors: Daniel King Tags: asbestos exposure asbestos-contaminated talc California Court of Appeal Carol Schoeniger Cashmere Bouquet Colgate-Palmolive Gwen Myers Idee Fox Imerys Talc North America Johnson & Johnson Judith Winkel Los Angeles Superior Court Ma Source Type: news

Clovis Oncology gets FDA fast-tracked review date for ovarian cancer drug
The U.S. Food and Drug Administration has granted a fast-tracked review of using a Clovis Oncology drug to treat a wider range of ovarian cancer patients. The Boulder-based company (Nasdaq: CLVS) seeks approval to use its ovarian cancer drug, rucaparib, as a maintenance treatment in women “with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are platinum sensitive” and regardless of their genetic profile. The FDA says it will make a decision by April 6, 2018,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 6, 2017 Category: Pharmaceuticals Authors: Greg Avery Source Type: news

Clovis Oncology gets FDA fast-tracked review date for ovarian cancer drug
The U.S. Food and Drug Administration has granted a fast-tracked review of using a Clovis Oncology drug to treat a wider range of ovarian cancer patients. The Boulder-based company (Nasdaq: CLVS) seeks approval to use its ovarian cancer drug, rucaparib, as a maintenance treatment in women “with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are platinum sensitive” and regardless of their genetic profile. The FDA says it will make a decision by April 6, 2018,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 6, 2017 Category: Biotechnology Authors: Greg Avery Source Type: news

Return of skin cancer could be predicted by blood test
Early warning system for cancer return is possible Related items fromOnMedica Searching for a blood test to monitor ovarian cancer Lung cancer blood test Cheap blood test could boost prostate cancer treatment Underused cancer test could improve treatment of colon cancer Blood test may pick up bladder cancer ’s return before symptoms appear (Source: OnMedica Latest News)
Source: OnMedica Latest News - December 6, 2017 Category: UK Health Source Type: news

Consistently lower cancer survival rates for black patients in U.S.
(Reuters Health) - Whether it's colon cancer, breast cancer, or ovarian cancer, survival rates in the U.S. are lower for black people than for white people, three new studies show. (Source: Reuters: Health)
Source: Reuters: Health - December 5, 2017 Category: Consumer Health News Tags: healthNews Source Type: news